Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4105-4110

  Upadhyay, Jyoti ^a   Shekarriz, Bijan ^a   Nemeth, Jeffrey A ^a   Dong, Zhong ^a   Cummings, Glenn D ^a   Fridman, Rafael ^a   Sakr, Wael ^a   Grignon, David J ^a   Cher, Michael L ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A;

ADULT; AGED; ARTICLE; CANCER GRADING; CELLULAR DISTRIBUTION; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM;

ADULT; AGED; AMINO ACID SEQUENCE; BLOTTING, WESTERN; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; STAINING AND LABELING;

EID: 0033376888     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Matrisian, L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet., 6: 121-125, 1990.
2. Liotta, L. A., Tryggvasonn, K., Garbisa, S., Hart, I., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284: 67-68, 1993.
3. Stetler-Stevenson, W. J., Aznavoorian, S., and Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
4. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370: 61-65, 1994.
5. Corcoran, M. L., Hewitt, R. E., Kleiner, D. E., Jr., and Stetler-Stevenson, W. J. MMP-2: expression, activation and inhibition. Enzyme Prot., 49: 7-19, 1996.
6. Nomura, H., Sato, H., Seiki, M., Mai, M., and Okada, Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinoma. Cancer Res., 55: 3263-3266, 1995.
7. Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M., and Okada, Y. Expression and tissue localization of membrane types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res., 57: 2055-2060, 1997.
8. Wood, M., Fudge, K., Mohler, L., Frost, A. R., Garcia, F., Wang, M., and Stearns, M. E. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin. Exp. Metastasis, 15: 246-258, 1996.
9. Sakr, W. A., Grignon, D. J., Visscher, D. W., Wolman S. R., and Crissman, J. D. Evaluating the radical prostatectomy specimen I: a protocol for establishing prognostic parameters and defining genetic abnormalities. J. Urol. Pathol., 3: 377-384, 1995.
10. Toth, M., Gervasi, D. C., and Fridman, R. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. Cancer Res., 57: 3159-3167, 1997.
11. Hoyhtya, M., Fridman, R., Komarek, D., Porter-Jordan, K., Stetler- Stevenson, W. G., Liotta, L. A., and Liang, C. M. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int. J. Cancer, 56: 500-505, 1994.
12. Sato, H., and Seiki, M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J. Biochem., 119: 209-215, 1996.
13. Gilles, C., Polette, M., Piette, J., Munaut, C., Thompson, E. W., Birmbaut, P., and Foidart, J. M. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer, 65: 209-213, 1996.
14. Polette, M., Mawrocki, B., Gilles, C., Sato, H., Seiki, M., Tournier, J. M., and Birembaut, P. MT-MMP expression and localization in human lung and breast cancer. Virchows Arch., 428: 29-35, 1996.
15. Kitagawa, Y., Kunimi, K., Ito, H., Sato, H., Uchibayashi, T., Okada, Y., Seiki, M., and Namiki, M. Expression and tissue localization of membrane types 1, 2, and 3 matrix metalloproteinases in human urothehal carcinoma. J. Urol., 160: 1540-1545, 1998.
16. Bostwick, D., Amin, M. B., Dundore, P., Marsh, W., and Schultz, D. S. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum. Pathol., 24: 298-310, 1993.
17. Boag, A. H., and Young, I. D. Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. Mod. Pathol., 6: 65-68, 1993.
18. r 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53: 878-883, 1993.
19. Montironi, R., Fabris, G., Lucarini, G., and Biagini, G. Location of 72-kd metalloproteinase (type IV collagenase) in untreated prostatic adenocarcinoma. Pathol. Res. Pract., 191: 1140-1146, 1995.
20. Montironi, R., Lucarini, G., Castaldini, C., Galluzzi, C. M., Biagini, G., and Fabris, G. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Anticancer Res., 16: 2057-2062, 1996.